• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 filed by Eastman Chemical Company

    11/5/25 4:48:06 PM ET
    $EMN
    Major Chemicals
    Industrials
    Get the next $EMN alert in real time by email
    S-8 1 a2025forms-8.htm S-8 Document

    As filed with the Securities and Exchange Commission on November 5, 2025
    Registration No. 333-
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    FORM S-8

    REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933


    EASTMAN CHEMICAL COMPANY
    (Exact name of registrant as specified in its charter)
    Delaware
    (State or other jurisdiction of
    incorporation or organization)
    62-1539359
    (I.R.S. Employer
    Identification No.)

    200 South Wilcox Drive
    Kingsport, Tennessee
    (Address of principal executive offices)
    37662
    (Zip Code)

    EASTMAN INVESTMENT AND EMPLOYEE STOCK OWNERSHIP PLAN
    (Full title of the plan)

    Iké G. Adeyemi
    Senior Vice President, Chief Legal Officer and Corporate Secretary
    EASTMAN CHEMICAL COMPANY
    200 South Wilcox Drive
    Kingsport, Tennessee 37662
    Telephone: (423) 229-2000
    (Name, address and telephone number,
    including area code, of agent for service)

    With copies to:
    Synne D. Chapman & Julia L. Petty
    Cleary Gottlieb Steen & Hamilton LLP
    One Liberty Plaza
    New York, New York 10006

    ________________________
    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non‑accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b‑2 of the Exchange Act.
    Large accelerated filer    ☒    Accelerated filer    ☐
    Non‑accelerated filer    ☐      Smaller reporting company    ☐
    Emerging growth company    ☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.  ☐




    EXPLANATORY NOTE

    Pursuant to General Instruction E of Form S-8, EASTMAN CHEMICAL COMPANY (the “Registrant”) is filing this registration statement on Form S-8 (this “Registration Statement”) with the U.S. Securities and Exchange Commission (the “Commission”) to register, in connection with the Registrant’s Eastman Investment and Employee Stock Ownership Plan, an additional 5,000,000 shares of the same class as registered under the Registrant’s effective registration statement on Form S-8, File No. 33-73810 filed with the Commission on January 4, 1994 (the “Earlier Registration Statement”). The contents of the Earlier Registration Statement, where applicable, are hereby incorporated by reference, except that the provisions contained in Part II of such Earlier Registration Statement are modified as set forth in this Registration Statement.

    PART II.

    INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

    Item 3.Incorporation of Documents by Reference.

    The following documents, as filed by the Registrant with the Commission pursuant to the Securities Exchange Act of 1934, as amended (the “Exchange Act”), are incorporated by reference in this Registration Statement:

    (1)The Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, filed with the Commission on February 14, 2025;

    (2)The Registrant’s Quarterly Report[s] on Form 10-Q for the fiscal quarters ended March 31, 2025, June 30, 2025, and September 30, 2025, filed with the Commission on April 25, 2025, August 1, 2025, and November 4, 2025, respectively;

    (3)The Registrant’s Current Reports on Form 8-K filed with the Commission on February 21, 2025, March 14, 2025, May 5, 2025, May 6, 2025, and June 27, 2025; and

    (4)The description of the Registrant’s Common Stock, par value $0.01 per share, contained in Exhibit 4.18 to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019, filed with the Commission on February 26, 2020, including any amendment or report filed for the purpose of updating such description.

    In addition, all reports and other documents filed by the Registrant with the Commission pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act on or after the date of this Registration Statement and prior to the filing of a post‑effective amendment to this Registration Statement that indicates that all securities offered hereunder have been sold or that deregisters all securities then remaining unsold shall be deemed to be incorporated by reference in this Registration Statement and to be part hereof from the date of filing of such documents; provided, however, that documents or information deemed to have been furnished and not filed in accordance with the rules of the Commission shall not be deemed incorporated by reference into this Registration Statement. Any document or any statement contained in this Registration Statement, in an amendment hereto or in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any subsequently filed document which also is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.

    Item 4.Description of Securities.

    Not applicable.




    Item 5.Interests of Named Experts and Counsel.

    Not applicable.

    Item 6.Indemnification of Directors and Officers.

    Limitation on Liability of Directors. Pursuant to authority conferred by Section 102 of the Delaware General Corporation Law, as amended (the "DGCL"), Article VIII ("Article VIII") of the Company's Amended and Restated Certificate of Incorporation (the "Certification of Incorporation") eliminates the personal liability of the Company's directors to the Company or its stockholders for monetary damages for breach of fiduciary duty. Directors remain liable for (i) any breach of the duty of loyalty to the Company or its stockholders, (ii) any act or omission not in good faith or which involves intentional misconduct or a knowing violation of law, (iii) any violation of Section 174 of the DGCL, which proscribes the payment of dividends and stock purchases or redemptions under certain circumstances, and (iv) any transaction from which directors derive an improper personal benefit.
    Article VIII further provides that any future repeal or amendment of its terms will not adversely affect any rights of directors existing thereunder with respect to acts or omissions occurring prior to such repeal or amendment. Article VIII also incorporates any future amendments to Delaware law which further eliminate or limit the liability of directors.

    Indemnification and Insurance. In accordance with Section 145 of the DGCL, which allows or requires the indemnification of directors and officers under certain circumstances, Article VII of the Certificate of Incorporation (" Article VII") and certain provisions of the Company's Amended and Restated Bylaws, as amended (the "Bylaws"), grant the Company's directors and officers a right to indemnification for all expenses relating to civil, criminal, administrative, or investigative procedures to which they are a party (i) by reason of the fact that they are or were directors or officers of the Company or (ii) by reason of the fact that, while they are or were directors or officers of the Company, they are or were serving at the request of the Company as directors, trustees, officers, employees, or agents of another enterprise, the Bylaws further provide that an advancement for any such expenses shall only be made upon delivery to the Company by the indemnitee of an undertaking to repay all amounts so advanced if it is ultimately determined by final judicial decision from which there is no further right to appeal that such indemnitee is not entitled to be indemnified under Article VII or otherwise.

    In addition, Article VII provides that directors and officers therein described shall be indemnified to the fullest extent not prohibited by Section 145 of the DGCL, or any successor provisions or amendments thereto. In the event that any such successor provisions or amendments provide indemnification rights broader than permitted prior thereto, Article VII allows such broader indemnification rights to apply retroactively with respect to any predating alleged action or inaction and also allows the indemnification to continue after an indemnitee has ceased to be a director or officer of the Company and to inure to the benefit of the indemnitee's heirs, executors, and administrators.

    If a claim for indemnification under Article VII is not paid in full by the Company or an advancement of expenses is not made by the Company within a prescribed period of time and suit is filed in relation thereto, the Bylaws entitle the indemnitee to recover the expense of prosecuting or defending such suit, if the indemnitee is successful in whole or in part.

    The Bylaws also entitle the indemnitee to recover the expense of defending a suit brought by the Company to recover an advancement of expenses pursuant to the terms of an undertaking, if the indemnitee is successful in whole or in part. The Bylaws also entitle the Company to recover advanced expenses upon final adjudication that the indemnitee has not met the applicable standard of conduct set forth in Section 145 of the DGCL. Under the Bylaws, the burden of proving that the indemnitee is not entitled to be indemnified lies with the Company.




    Article VII further provides that the right to indemnification is not exclusive of any other right that any indemnitee may have or thereafter acquire under any statute, the Certificate of Incorporation or Bylaws, any agreement or vote of stockholders or disinterested directors, or otherwise, and permits, but does not require, the Company to indemnify and advance expenses to its agents and employees to the same (or any lesser or greater) extent as directors and officers.

    Insofar as indemnification for liabilities arising under the Securities Act of 1933, as amended (the "Securities Act"), may be permitted for directors, officers, and controlling persons pursuant to the foregoing provisions, the Company has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable.

    The Bylaws authorize the Company to purchase insurance for directors, officers, trustees, employees, or agents of the Company or another enterprise against any expense, liability, or loss, whether or not the Company would have the power to indemnify such persons against such expense or liability under the DGCL. The Company intends to maintain insurance coverage for its officers and directors, as well as insurance coverage to reimburse the Company for potential costs of its corporate indemnification of directors and officers.

    Item 7.Exemption from Registration Claimed.

    Not applicable.

    Item 8.Exhibits.

    Exhibit Number
    Description
    4.01Amended and Restated Certificate of Incorporation of Eastman Chemical Company (incorporated herein by reference to Exhibit 3.01 to the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2012)
    4.02Amended and Restated Bylaws of Eastman Chemical Company (incorporated herein by reference to Exhibit 3.2 to the Company's Current Report on Form 8-K dated December 1, 2022)
    4.03Form of Eastman Chemical Company common stock certificate (incorporated herein by reference to Exhibit 4.01 to the Company’s Quarterly Report on Form 10-K for the year ended December 31, 2024)
    4.04Amended and Restated Eastman Investment and Employee Stock Ownership Plan, dated as of January 1, 2019
    4.05Amendment 2020-1 to the Eastman Investment and Employee Stock Ownership Plan, dated as of December 11, 2020
    4.06Amendment 2021-1 to the Eastman Investment and Employee Stock Ownership Plan, dated as of September 23, 2021
    4.07Amendment 2021-2 to the Eastman Investment and Employee Stock Ownership Plan, dated as of November 29, 2021
    4.08Amendment 2021-3 to the Eastman Investment and Employee Stock Ownership Plan, dated as of December 13, 2021
    4.09Amendment 2022-1 to the Eastman Investment and Employee Stock Ownership Plan, dated as of December 9, 2022
    4.10Amendment 2025-1 to the Eastman Investment and Employee Stock Ownership Plan, dated as of March 12, 2025
    5.01Opinion of Cleary Gottlieb Steen & Hamilton LLP
    23.01Consent of Cleary Gottlieb Steen & Hamilton LLP (included in Exhibit 5.1)
    23.02Consent of PricewaterhouseCoopers LLP
    24.01Power of Attorney
    107Filing Fee Table



    Item 9.Undertakings.

    The undersigned Registrant hereby undertakes:

    (1)To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:

    i.To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933;
    ii.To reflect in the prospectus any facts or events arising after the effective date of the Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the Registration Statement;
    iii.To include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement or any material change to such information in the Registration Statement;

    provided, however, that paragraphs (l)(i) and (l)(ii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in periodic reports filed by the Registrant pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the Registration Statement.

    (2)That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

    (3)To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

    (4)That, for purposes of determining any liability under the Securities Act of 1933, each filing of the Registrant's annual report pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (and where applicable, each filing of an employee benefit plan's annual report pursuant to Section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the Registration Statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

    Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers, and controlling persons of the Registrant pursuant to the foregoing provisions or otherwise, the Registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer, or controlling person of the Registrant in the successful defense of any action, suit, or proceeding) is asserted by such director, officer, or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.





    SIGNATURES

    Pursuant to the requirements of the Securities Act, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S‑8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Kingsport, Tennessee on the 5th day of November, 2025.
    EASTMAN CHEMICAL COMPANY
    Date: November 5, 2025
    By:/s/ Iké G. Adeyemi
    Name: Iké G. Adeyemi
    Title: Senior Vice President, Chief Legal Officer and Corporate Secretary

    Pursuant to the requirements of the Securities Act, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
    /s/ Mark J. CostaChief Executive Officer and DirectorNovember 5, 2025
    Mark J. Costa(Principal Executive Officer)
    /s/ William T. McLain, Jr.Executive Vice President and Chief Financial OfficerNovember 5, 2025
    William T. McLain, Jr.(Principal Financial Officer)
    /s/ Michelle R. StewartVice President, Chief Accounting Officer and Corporate ControllerNovember 5, 2025
    Michelle R. Stewart(Principal Accounting Officer)
    *DirectorNovember 5, 2025
    Humberto P. Alfonso
    *DirectorNovember 5, 2025
    Damon Audia
    *DirectorNovember 5, 2025
    Brett D. Begemann
    *DirectorNovember 5, 2025
    Eric L. Butler
    *DirectorNovember 5, 2025
    Linnie M. Haynesworth
    *DirectorNovember 5, 2025
    Julie F. Holder
    *DirectorNovember 5, 2025
    Renée J. Hornbaker
    *DirectorNovember 5, 2025
    Kim A. Mink



    *DirectorNovember 5, 2025
    James J. O’Brien
    *DirectorNovember 5, 2025
    Donald W. Slager
    *Iké G. Adeyemi also signs on behalf of the noted individuals pursuant to the Power of Attorney filed as Exhibit 24.1.

    Get the next $EMN alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $EMN

    DatePrice TargetRatingAnalyst
    4/28/2025$76.00Overweight → Neutral
    Analyst
    4/9/2025$91.00Sector Perform → Outperform
    RBC Capital Mkts
    4/4/2025$101.00Neutral → Buy
    Citigroup
    4/3/2025$105.00Neutral → Outperform
    Mizuho
    1/14/2025$115.00 → $109.00Neutral → Buy
    BofA Securities
    12/18/2024$118.00 → $104.00Buy → Neutral
    Citigroup
    11/26/2024$110.00 → $125.00Equal Weight → Overweight
    Wells Fargo
    10/16/2024$114.00 → $119.00Buy → Neutral
    BofA Securities
    More analyst ratings

    $EMN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Audia Damon J

    4 - EASTMAN CHEMICAL CO (0000915389) (Issuer)

    10/9/25 6:24:22 PM ET
    $EMN
    Major Chemicals
    Industrials

    SEC Form 4 filed by Director Hornbaker Renee J

    4 - EASTMAN CHEMICAL CO (0000915389) (Issuer)

    10/9/25 6:24:12 PM ET
    $EMN
    Major Chemicals
    Industrials

    SEC Form 4 filed by Director Haynesworth Linnie M

    4 - EASTMAN CHEMICAL CO (0000915389) (Issuer)

    10/9/25 6:24:05 PM ET
    $EMN
    Major Chemicals
    Industrials

    $EMN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Eastman Chemical downgraded by Analyst with a new price target

    Analyst downgraded Eastman Chemical from Overweight to Neutral and set a new price target of $76.00

    4/28/25 8:33:13 AM ET
    $EMN
    Major Chemicals
    Industrials

    Eastman Chemical upgraded by RBC Capital Mkts with a new price target

    RBC Capital Mkts upgraded Eastman Chemical from Sector Perform to Outperform and set a new price target of $91.00

    4/9/25 8:31:36 AM ET
    $EMN
    Major Chemicals
    Industrials

    Eastman Chemical upgraded by Citigroup with a new price target

    Citigroup upgraded Eastman Chemical from Neutral to Buy and set a new price target of $101.00

    4/4/25 8:24:36 AM ET
    $EMN
    Major Chemicals
    Industrials

    $EMN
    SEC Filings

    View All

    $EMN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $EMN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    SEC Form S-8 filed by Eastman Chemical Company

    S-8 - EASTMAN CHEMICAL CO (0000915389) (Filer)

    11/5/25 4:48:06 PM ET
    $EMN
    Major Chemicals
    Industrials

    SEC Form 10-Q filed by Eastman Chemical Company

    10-Q - EASTMAN CHEMICAL CO (0000915389) (Filer)

    11/4/25 3:53:21 PM ET
    $EMN
    Major Chemicals
    Industrials

    Eastman Chemical Company filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - EASTMAN CHEMICAL CO (0000915389) (Filer)

    11/3/25 4:19:05 PM ET
    $EMN
    Major Chemicals
    Industrials

    EVP, AFP, Mfg., WWEC & HSE Smith Brian Travis bought $119,595 worth of shares (1,750 units at $68.34), increasing direct ownership by 12% to 16,732 units (SEC Form 4)

    4 - EASTMAN CHEMICAL CO (0000915389) (Issuer)

    8/29/25 4:01:38 PM ET
    $EMN
    Major Chemicals
    Industrials

    Director Obrien James J /Ky bought $99,776 worth of shares (1,450 units at $68.81), increasing direct ownership by 27% to 6,828 units (SEC Form 4)

    4 - EASTMAN CHEMICAL CO (0000915389) (Issuer)

    8/28/25 4:14:09 PM ET
    $EMN
    Major Chemicals
    Industrials

    Director Mink Kim Ann bought $100,601 worth of shares (1,450 units at $69.38), increasing direct ownership by 104% to 2,840 units (SEC Form 4)

    4 - EASTMAN CHEMICAL CO (0000915389) (Issuer)

    8/28/25 4:13:44 PM ET
    $EMN
    Major Chemicals
    Industrials

    Eastman Announces Third-Quarter 2025 Financial Results

    Eastman Chemical Company (NYSE:EMN) announced its third-quarter 2025 financial results. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251103079329/en/ Delivered strong operating cash flow of $402 million consistent with the prior-year quarter, underscoring our commitment to cash generation. Demonstrated significant progress on inventory actions, with an approximately $200 million reduction from second-quarter 2025 levels. Continued commercial excellence in defending the value of our products in a weakening economic environment. Remain on track to reduce cost structure by more than $75 million, net of inflation, in 202

    11/3/25 4:15:00 PM ET
    $EMN
    Major Chemicals
    Industrials

    Solstice Advance Materials and Qnity Electronics Set to Join S&P 500; Others to Join S&P SmallCap 600

    NEW YORK, Oct. 27, 2025 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P SmallCap 600: Solstice Advance Materials Inc. (NASD: SOLS) will replace CarMax Inc. (NYSE:KMX) in the S&P 500, and CarMax will replace USANA Health Sciences Inc. (NYSE:USNA) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, October 31. S&P 500 and 100 constituent Honeywell International Inc. (NASD: HON) is spinning off Solstice Advance Materials in a transaction expected to be completed on October 30. Post spin-off, Honeywell International will remain in the S&P 500 and 100. CarMax and USANA Health Sciences no longer represent the large cap and small c

    10/27/25 6:10:00 PM ET
    $CAL
    $DD
    $EMN
    Shoe Manufacturing
    Consumer Discretionary
    Major Chemicals
    Industrials

    Eastman Schedules Third-Quarter 2025 Financial Results News Release and SEC Form 8-K Filing, Teleconference and Webcast, and Release of Additional Information

    Eastman Chemical Company (NYSE:EMN): Financial Results Release:     Monday, Nov. 3, 2025 Approximately 4:15 p.m. Eastern Time Via wire distribution and www.eastman.com, News Center and SEC Form 8-K filing.     Advance Slides, Webcast and Teleconference:     Tuesday, Nov. 4, 2025 8:00 a.m. Eastern Time Via listen-only live webcast and teleconference. Advance slides and prepared remarks: posted Monday, Nov. 3, evening at investors.eastman.com Webcast: Eastman Q3 2025 Webcast to join live webcast Teleconference: Toll-Free dial-in number +1 (833) 470-1428 Passcode: 369653   Teleconference Pre-Registration:  

    10/6/25 4:15:00 PM ET
    $EMN
    Major Chemicals
    Industrials

    $EMN
    Financials

    Live finance-specific insights

    View All

    Eastman Announces Third-Quarter 2025 Financial Results

    Eastman Chemical Company (NYSE:EMN) announced its third-quarter 2025 financial results. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251103079329/en/ Delivered strong operating cash flow of $402 million consistent with the prior-year quarter, underscoring our commitment to cash generation. Demonstrated significant progress on inventory actions, with an approximately $200 million reduction from second-quarter 2025 levels. Continued commercial excellence in defending the value of our products in a weakening economic environment. Remain on track to reduce cost structure by more than $75 million, net of inflation, in 202

    11/3/25 4:15:00 PM ET
    $EMN
    Major Chemicals
    Industrials

    Eastman Board Declares Dividend

    The Board of Directors of Eastman Chemical Company (NYSE:EMN) has declared a quarterly cash dividend of $0.83 per share on the company's common stock. The dividend is payable Oct. 7, 2025, to stockholders of record as of Sept. 15, 2025. Founded in 1920, Eastman is a global specialty materials company that produces a broad range of products found in items people use every day. With the purpose of enhancing the quality of life in a material way, Eastman works with customers to deliver innovative products and solutions while maintaining a commitment to safety and sustainability. The company's innovation-driven growth model takes advantage of world-class technology platforms, deep customer

    8/7/25 6:45:00 PM ET
    $EMN
    Major Chemicals
    Industrials

    Eastman Announces Second-Quarter 2025 Financial Results

    Eastman Chemical Company (NYSE:EMN) announced its second-quarter 2025 financial results. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250731345203/en/ Continued commercial excellence by our teams keeping price-cost in specialties stable and defending market share Strong results in Additives & Functional Products driven by mix improvement and leverage to stable end markets and solid results in Advanced Materials despite significant challenges in key end markets Circular platform continues making progress, with methanolysis plant setting new production records, strong customer engagement with new business pipeline buildin

    7/31/25 4:15:00 PM ET
    $EMN
    Major Chemicals
    Industrials

    $EMN
    Leadership Updates

    Live Leadership Updates

    View All

    Solstice Advance Materials and Qnity Electronics Set to Join S&P 500; Others to Join S&P SmallCap 600

    NEW YORK, Oct. 27, 2025 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P SmallCap 600: Solstice Advance Materials Inc. (NASD: SOLS) will replace CarMax Inc. (NYSE:KMX) in the S&P 500, and CarMax will replace USANA Health Sciences Inc. (NYSE:USNA) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, October 31. S&P 500 and 100 constituent Honeywell International Inc. (NASD: HON) is spinning off Solstice Advance Materials in a transaction expected to be completed on October 30. Post spin-off, Honeywell International will remain in the S&P 500 and 100. CarMax and USANA Health Sciences no longer represent the large cap and small c

    10/27/25 6:10:00 PM ET
    $CAL
    $DD
    $EMN
    Shoe Manufacturing
    Consumer Discretionary
    Major Chemicals
    Industrials

    Eastman Schedules Third-Quarter 2025 Financial Results News Release and SEC Form 8-K Filing, Teleconference and Webcast, and Release of Additional Information

    Eastman Chemical Company (NYSE:EMN): Financial Results Release:     Monday, Nov. 3, 2025 Approximately 4:15 p.m. Eastern Time Via wire distribution and www.eastman.com, News Center and SEC Form 8-K filing.     Advance Slides, Webcast and Teleconference:     Tuesday, Nov. 4, 2025 8:00 a.m. Eastern Time Via listen-only live webcast and teleconference. Advance slides and prepared remarks: posted Monday, Nov. 3, evening at investors.eastman.com Webcast: Eastman Q3 2025 Webcast to join live webcast Teleconference: Toll-Free dial-in number +1 (833) 470-1428 Passcode: 369653   Teleconference Pre-Registration:  

    10/6/25 4:15:00 PM ET
    $EMN
    Major Chemicals
    Industrials

    Eastman Schedules Second-Quarter 2025 Financial Results News Release and SEC Form 8-K Filing, Teleconference and Webcast, and Release of Additional Information

    Eastman Chemical Company (NYSE:EMN): Financial Results Release:     Thursday, July 31, 2025 Approximately 4:15 p.m. Eastern Time Via wire distribution and www.eastman.com, News Center and SEC Form 8-K filing.   Advance Slides, Webcast and Teleconference:     Friday, August 1, 2025 8:00 a.m. Eastern Time Via listen-only live webcast and teleconference. Advance slides and prepared remarks: posted Thursday, July 31, evening at investors.eastman.com Webcast: Eastman Q2 2025 Webcast to join live webcast Teleconference: Toll-Free dial-in number +1 (833) 470-1428 Passcode: 243966   Teleconference Pre-Registrat

    7/1/25 10:00:00 AM ET
    $EMN
    Major Chemicals
    Industrials

    $EMN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Eastman Chemical Company (Amendment)

    SC 13G/A - EASTMAN CHEMICAL CO (0000915389) (Subject)

    2/13/24 4:55:51 PM ET
    $EMN
    Major Chemicals
    Industrials

    SEC Form SC 13G/A filed by Eastman Chemical Company (Amendment)

    SC 13G/A - EASTMAN CHEMICAL CO (0000915389) (Subject)

    1/4/24 8:11:03 AM ET
    $EMN
    Major Chemicals
    Industrials

    SEC Form SC 13G/A filed by Eastman Chemical Company (Amendment)

    SC 13G/A - EASTMAN CHEMICAL CO (0000915389) (Subject)

    2/13/23 2:49:26 PM ET
    $EMN
    Major Chemicals
    Industrials